Durect

(NASDAQ:DRRX)

DURECT Corporation - Common Stock recently split on Tuesday, December 6, 2022 with a ratio of 1:10

$3.66

3.27[838.46%]

Last update: 3:17PM (Delayed 15-Minutes)
Get Real Time Here

Day Range3.48 - 3.99	52 Wk Range3.6 - 10.9	Open / Close3.99 / -	Float / Outstanding197.8M / 227.9M
Vol / Avg.150.2K / 22.4K	Mkt Cap834M	P/E-	50d Avg. Price5.22
Div / Yield-	Payout Ratio-	Total Float197.8M	EPS-0.01

Durect Stock (NASDAQ:DRRX), Quotes and News Summary

Q: What sector and industry does Durect (DRRX) operate in?

Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Durect Stock (NASDAQ: DRRX) stock price, news, charts, stock research, profile.

Day Range3.48 - 3.99	52 Wk Range3.6 - 10.9	Open / Close3.99 / -	Float / Outstanding197.8M / 227.9M
Vol / Avg.150.2K / 22.4K	Mkt Cap834M	P/E-	50d Avg. Price5.22
Div / Yield-	Payout Ratio-	Total Float197.8M	EPS-0.01

Sector: Health Care.Industry: Pharmaceuticals

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Earnings

Q4 2022		Est.		Actual		Surprise
EPS		(EXPECTED)2023-03-06
REV		(EXPECTED)2023-03-06

Q3 2022		Est.		Actual		Surprise
EPS		-0.010		-0.010		0.0000
REV		12.990M		11.977M		-1.013M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

How do I buy Durect (DRRX) stock?

You can purchase shares of Durect (NASDAQ: DRRX) through any online brokerage.

View our list of the best stock brokerages.

Who are Durect's (DRRX) competitors?

Other companies in Durect’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL) and Reata Pharmaceuticals (NASDAQ:RETA).

What is the target price for Durect (DRRX) stock?

The latest price target for Durect (NASDAQ: DRRX) was reported by HC Wainwright & Co. on Wednesday, May 5, 2021. The analyst firm set a price target for 6.00 expecting DRRX to rise to within 12 months (a possible 63.93% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Durect (DRRX)?

The stock price for Durect (NASDAQ: DRRX) is $3.66 last updated Today at December 6, 2022, 8:17 PM UTC.

Does Durect (DRRX) pay a dividend?

There are no upcoming dividends for Durect.

When is Durect (NASDAQ:DRRX) reporting earnings?

Durect’s Q4 earnings are confirmed for Monday, March 6, 2023.

Is Durect (DRRX) going to split?

There is no upcoming split for Durect.

What sector and industry does Durect (DRRX) operate in?

Durect is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

SPY

QQQ

BTC/USD

DIA

GLD

TLT

SPY

QQQ